Amylyx Pharmaceuticals
AMLX
AMLX
136 hedge funds and large institutions have $262M invested in Amylyx Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10.73% more ownership
Funds ownership: 72.67% → 83.41% (+11%)
14% less call options, than puts
Call options by funds: $524K | Put options by funds: $606K
Holders
136
Holding in Top 10
1
Calls
$524K
Puts
$606K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$8.85M | |
| 3 | +$6.45M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.73M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$5.47M |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$1.55M | |
| 3 | -$1.39M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.32M |
| 5 |
Walleye Capital
New York
|
-$953K |